A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma

Clinical trial NCT05244642 · UNKNOWN

Trial details

NCT number: NCT05244642
Sponsor: Akeso
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin Disease Lymphoma

Start date: 2022-02-15
Primary completion: 2025-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.